Responsible for driving field sales force execution for Cresemba (Transplant Medicine), Veozah (non HRT Therapy), Lexiscan and Ambisome.Span of control for 8 Healthcare System/Hospital Account Specialists throughout Southeastern United States.- In first year took team from (7 of 7) to (3 of 7) achieving companies Alpine Award.- #1 Team in the launch of Veozah, resulting in National Product Winner award and winning both rounds of 'Turn Up the Heat' award.- Achieved QTR over QTR double-digit growth for Cresemba (a product in it's 8th year). This was done with out contracting or managed care wins.- #1 for Cresemba in FYQ1, FYQ2 and FYQ3- Upon hiring, refocused the sales team by implementing new standards and expectations, resulting in increased performances and outcomes.- Recruited and onboarded 50% of the sales team due to vacancies.- Developed a comprehensive pre-launch guide for Veozah, which was adopted by Healthcare Systems Division.- Collaborated with analytics team to develop and synthesize reports for Leadership and Sales teams, enhancing targeting of 'abandoned and rejected' prescriptions to increase fulfillment rates.- Led Healthcare Systems in the successful Optima integration transformation.- Transitioned team from Cardiovascular Sales Model due to generic entry.- Diagnosed issues impacting HUB services between the sales professionals and the customers. Developed training to assist both sales leaders and territory specialists in the field.

Providing services for SCYNEXISResponsible for driving field sales force launch execution for start-up organization of Brexafemme (first in class, prescription, anti-fungal oral treatment of vaginal yeast infections).- Span of control for 7 District Sales Managers and 69 Representatives (59 Field Based and 10 Inside Sales).- Was hired on after launch and was responsible for revamping corporate culture and execution tactics within sales force and relationship with the client.- Successfully led sales force through multiple strategic shifts and sales force size restrictions for increased sales quarter over quarter.

Providing services for Pharmacyclics, An Abbvie CompanySpan of control for 8 Hematology Clinical Account Specialists throughout Southeastern United States. Responsible for commercial sales of Imbruvica (used to treat B cell cancers) for Waldenstrom's Macroglobulinemia and Mantle Cell Lymphoma

Second line leadership role with a span of control for 6 Regional Sales Directors and 55 Maternal Women’s Health Sales Specialists throughout Eastern-half of the United States. Responsible for commercial sales of specialty injectable (orphan drug) Makena, Makena Single-Dose-Vial, Makena Auto-Injector and Cord Blood Registry.- Drove sales force launch for Makena resulting in double digit growth 2 years in a row and 90% conversion of market in 9 months to single-dose vial (2016), and 60% conversion to auto-injector in 9 weeks, 80% in 20 weeks, outperforming analogues by >20% (2018).- Mobilized sales force to execute protection-based initiatives amid loss of exclusivity yielding 68% market share 2+ years post generic entry with 8 competitors.- Active member of Cord Blood Registry (CBR) integration team dedicated to sales force readiness with evolved business model (pharmaceutical + medical device/consumer product); served as interim sales operations director for CBR to ensure efficiency and realize synergies.- Led teams through multiple size and structure reorganizations resulting in heightened change agility among team members.- Seamless coordination with numerous cross functional overlaps (systems of care, managed markets, medical, marketing, HR, finance, operations, etc). - Coaching concentrated on capitalizing on individual strengths leading to increased market penetration and strong team performance. Produced multiple President Club Winners and developed direct reports to higher levels of responsibility within organization.- President’s Club 2017 and 2018.

Front line leadership role with a span of control of 10 Maternal Women’s Health Sales Specialists throughout Gulf Coast/Mid South of the United States. Responsible for commercial sales of specialty injectable (orphan drug) Makena.- Seamless coordination with numerous cross functional overlaps (systems of care, managed markets, medical, marketing, HR, finance, operations, etc).- Innovative state-specific business plans developed in conjunction with cross functional matrix partners to navigate the highly complex environment that ensured seamless execution and distribution of Makena Injectable.- Coaching concentrated on capitalizing on individual strengths leading to increased market penetration and strong team performance. Produced multiple President Club Winners and developed direct reports to higher levels of responsibility within organization.

(Company was purchased by AMAG in 2014)Front line leadership role with a span of control of 10 Maternal Women’s Health Sales Specialists throughout Gulf Coast/Mid South of the United States. Responsible for commercial sales of specialty injectable (orphan drug) Makena, Clindesse, Gynezole, Evamist and Repliva 21/7.- Diagnosed issues impacting productivity reporting of sales activities, resulting in increased efficiencies and more accurate reporting nationally for organization.- Strategic partner in development of pre-launch initiatives for the national launch of orphan drug, Makena. Hired majority of sales force for the launch of Makena.- Developed multiple key opinion leaders which was instrumental in overcoming institutional and market concerns/obstacles.- Coordinated sales strategies for buy-and-bill and alternative-site-distribution for Makena, which led to increased utilization and access of Makena for providers and patients in restrictive markets.- Led sales teams through FDA challenges, structure reorganizations and bankruptcy challenges resulting in heightened change agility among team members.

Front line leadership role with a span of control of 10 Territory/Hospital Representatives throughout Alabama and Gulf Coast. Responsible for commercial and hospital sales of Levaquin, Ultram, Ultracet, Elmiron, Ditropan XL, Aciphex and Ultracet. - Coaching concentrated on capitalizing on individual strengths leading to increased market penetration and strong team performance. Produced multiple President Club and Japan Trip Winners and developed direct reports to higher levels of responsibility within organization.- Innovative business plans (Alabama/Florida Panhandle) developed in conjunction with cross functional matrix partners to navigate the highly complex environment that ensured seamless execution which resulted in 60% Market Share at 3rd Tier as compared to 2nd Tier Competition.Awarded:- Japan Trip Winner 2004 - Top Levaquin IV/PO Sales Nationally- Region Business Director Award 2004.

Hospital Representative with responsibility for Teaching (Vanderbilt University Medical Center), Community and Military Treatment Facilities in Middle Tennessee for the promotion of Levaquin IV/PO and Ultram.- Gained inclusion of Levaquin IV/PO on formularies and treatment protocols.- Blunted competitive activity through contract negotiations, financial analysis and clinical selling to multiple specialties and departments.